Avricore Health Inc. shares surged by 7.69% in the last trading session, reflecting growing investor confidence.
In a notable turn of events, Avricore Health Inc. (AVCR.V) saw its stock price rise significantly, closing at CA$0.07. This 7.69% increase signals a positive shift in market sentiment towards the company, especially as it continues to expand its innovative HealthTab™ platform in the UK.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$8.21M
52W high
$0.10
52W low
$0.04
1W change
+27.27%
Beta
0.32
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
131.4%
Annualized
90-Day Vol
110.7%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.07
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.04 – C$0.11 |
| 60 trading days | C$0.07 | C$0.04 – C$0.13 |
| 90 trading days | C$0.07 | C$0.03 – C$0.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Keep an eye on Avricore's ongoing expansion efforts and financial health, as these factors could impact future stock performance.
Stock Price Increases by 7.69%
Avricore Health Inc.'s stock closed at CA$0.07, reflecting a significant rise that may be attributed to strategic financing and expansion plans.
Bull case
The recent financing of CA$1.254 million puts Avricore Health in a strong position to speed up its UK expansion. This could boost revenue and help the company gain a larger share of the healthcare technology market.
Bear case
Despite the positive movement, Avricore's current market cap of CA$8.8 million and its lack of profitability raise concerns about its long-term sustainability and ability to compete effectively.
Recent Performance Highlights
Avricore Health Inc. has seen a notable increase in its stock price, closing at CA$0.07 after a 7.69% rise in the last trading session. This boost may reflect investor optimism surrounding the company's strategic initiatives and expansion plans.
Strategic Financing and Growth Plans
The completion of a CA$1.254 million financing round shows Avricore's commitment to funding its expansion of the HealthTab™ platform in the UK. This move is crucial as the company aims to strengthen its presence in the healthcare technology sector, which could lead to increased revenue potential.
Market Outlook
While the recent surge in stock price is promising, investors should remain cautious. Avricore's market cap of CA$8.8 million and its current lack of profitability are factors that could impact long-term performance. Keeping track of the company's progress and financial health will be essential for potential investors.
Advertisement
